XML 278 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheet - GBP (£)
£ in Millions
Dec. 31, 2023
Dec. 31, 2022
Non-current assets    
Intangible assets [1] £ 7,042 £ 7,303
Property, plant and equipment 499 495
Right-of-use assets [1] 452 449
Investments in associated undertakings [1] 44 63
Other investments 21 23
Deferred tax assets 43 43
Contract costs [1] 224 215
Retirement benefit assets 3 3
Trade and other receivables 45 90
Derivative financial instruments 57 21
Non current assets 8,430 8,705
Current assets    
Other investments 1 1
Inventories 207 200
Trade and other receivables [1] 880 830
Current tax assets 33 36
Derivative financial instruments 14  
Cash and cash equivalents 1,562 2,170
Current assets 2,697 3,237
Current liabilities    
Trade and other payables [1] (1,144) (1,166)
Current tax liabilities (48) (60)
Provisions for liabilities and charges (94) (133)
Bank and other short-term borrowings [1] (1,134) (1,345)
Lease liabilities (127) (135)
Derivative financial instruments (32)  
Current liabilities (2,579) (2,839)
Net current assets 118 398
Non-current liabilities    
Other payables [1] (71) (90)
Bank and other long-term borrowings (3,153) (3,574)
Lease liabilities [1] (318) (325)
Deferred tax liabilities [1] (517) (513)
Retirement benefit obligations (28) (30)
Provisions for liabilities and charges [1] (357) (381)
Derivative financial instruments (16) (92)
Non current liabilities (4,460) (5,005)
Net assets 4,088 4,098
Equity Capital and reserves attributable to the Company's equity holders    
Share capital 25 25
Share premium 14 9
Other reserves 532 763
Retained earnings 3,518 3,302
Equity attributable to owners of parent 4,089 4,099
Non-controlling interests (1) (1)
Total equity £ 4,088 £ 4,098
[1] Goodwill, right-of-use assets, investments in associated undertakings, contract costs, accrued income, accruals, loans, long-term liabilities, lease liabilities, deferred tax liabilities, and provisions have been retrospectively adjusted in 2022, in accordance with IFRS 3, to reflect measurement period adjustments made relating to the Terminix acquisition (see Note B1).